|
Symbol
|
AAQ8SG | NUFRCH | KYGEDU | DFZCBL | OMFRCH | OKIRCH | RMA93V | ONJRCH | RMBA5V | AAGPTQ | KYKRDU | KYHCDU | KYMLDU | EQZRCH | KYNADU | KYNCDU | RMA70V | KYNYDU | KYLDDU | CCCBKB |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Barrier Reverse Convertible Worst Of | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Underlying
|
Alcon / Barry Callebaut AG / Cembra Money Bank / Lonza Group N | Alcon / Lonza Group N / Straumann Hldg. AG / Swisscom N | Ems-Chemie Hldg. AG / Lonza Group N / Sika AG | Alcon / Compagnie Financière Richemont SA / Lonza Group N / Swiss RE AG | Compagnie Financière Richemont SA / Kühne & Nagel Intl. AG / Lonza Group N / UBS Group AG | Holcim/Amrize Basket / Lonza Group N / Sika AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Barry Callebaut AG / Lonza Group N / Nestlé S.A. | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Lonza Group N / Sonova Hldg. AG / Straumann Hldg. AG | Lonza Group N / Nestlé S.A. / Roche PS | Lonza Group N / Novartis AG / Roche PS | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | BASF SE / Clariant AG / Lonza Group N | Julius Baer Group / Lonza Group N / Sika AG | Ems-Chemie Hldg. AG / Lonza Group N / Sika AG | Compagnie Financière Richemont SA / Lonza Group N / Straumann Hldg. AG / Zurich Insurance Group AG | Holcim AG / Sika AG / Lonza Group N | Holcim AG / Sika AG / Lonza Group N | Alcon / Lonza Group N / Novartis AG / Roche PS |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
13.10.2026 | 26.08.2026 | 29.06.2026 | 03.07.2026 | 08.07.2026 | 24.06.2026 | 12.01.2027 | 15.07.2026 | 05.01.2027 | 15.07.2026 | 24.07.2026 | 03.07.2026 | 31.07.2026 | 22.07.2026 | 10.08.2026 | 10.08.2026 | 10.08.2026 | 14.08.2026 | 24.07.2026 | 09.02.2027 |
| Bid | 95.62 | 100.32 | - | 102.19 | 101.16 | - | 94.40 | 76.11 | 94.50 | 101.56 | 100.00 | 99.65 | 99.90 | 53.04 | 61.00 | 61.10 | 101.40 | 65.60 | 61.85 | 89.66 |
| Ask | - | - | - | - | - | - | 95.40 | - | 95.50 | - | 100.90 | 100.70 | 100.90 | 53.57 | 62.00 | 62.10 | 102.40 | 66.60 | 62.85 | 90.46 |